We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Envision Healthcare Corp. reported first-quarter earnings of 65 cents per share that beat the Zacks Consensus Estimate by 14%. Earnings were, however, down 5.8% year over year.
Better-than-expected earnings were driven by revenue growth at the company’s Physicians Services segment.
Adjusted EBITDA for the first quarter came at $207.6 million, down 1.3% year over year.
Envision Healthcare Corporation Price, Consensus and EPS Surprise
The company reported net revenues of $2.08 billion, which beat the Zacks Consensus Estimate by 2.8% and improved 10.7% year over year.
Total operating expenses of $1.92 billion increased 11.4% year over year, due to higher salaries and benefits and operating cost.
Mixed Segment Performance
Physician Services
Net revenues from the segment were $1.77 billion, reflecting an increase of 13.2% year over year. The revenue growth was driven by 8.2% contribution from acquisitions and 2.7% from same contracts and 2.3% from new contracts.
Adjusted EBITDA was $150.1 million, unchanged year over year.
Ambulatory Services
Net revenues were $307.6 million, down 2.6% year over year, led by weather- and flu-related procedure cancellations.
For the reported quarter, adjusted EBITDA was $57.5 million, down 4.5% year over year.
Financial Update
Envision Healthcare had cash and cash equivalents of $767.4 million, down 1.4% year over year.
At Mar 31, 2018, Envision had total debt outstanding of $4.7 billion. The company’s ratio of total net debt to EBIDTA ratio was 4.2 times at the end of first-quarter 2018.
Net cash provided by operating activities was $37.3 million as of Mar 31, 2018, down from $98.1 million as of Mar 31, 2017.
Second-Quarter 2018 Guidance
The company expects adjusted EPS within the range of 83 cents and 90 cents and adjusted EBITDA in the band of $234-$246 million.
Full-Year 2018 Guidance
The company affirmed its previously provided revenue guidance for 2018, which calls for net revenues in the range of $8.35 billion to $8.53 billion. It, however, pulled up the lower end of the guidance for adjusted EBIDTA and adjusted EPS.
The company expects adjusted EBIDTA of $965 million to $1 billion (versus $960 million to $1 billion) and adjusted EPS between $3.49 and $3.70 (versus $3.46 and $3.70).
Among the other firms in the medical sector that have reported fourth-quarter earnings so far, the bottom line at Centene Corp. (CNC - Free Report) , Aetna Inc and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Envision Healthcare (EVHC) Q1 Earnings Beat, Revenues Rise
Envision Healthcare Corp. reported first-quarter earnings of 65 cents per share that beat the Zacks Consensus Estimate by 14%. Earnings were, however, down 5.8% year over year.
Better-than-expected earnings were driven by revenue growth at the company’s Physicians Services segment.
Adjusted EBITDA for the first quarter came at $207.6 million, down 1.3% year over year.
Envision Healthcare Corporation Price, Consensus and EPS Surprise
Envision Healthcare Corporation Price, Consensus and EPS Surprise | Envision Healthcare Corporation Quote
The company reported net revenues of $2.08 billion, which beat the Zacks Consensus Estimate by 2.8% and improved 10.7% year over year.
Total operating expenses of $1.92 billion increased 11.4% year over year, due to higher salaries and benefits and operating cost.
Mixed Segment Performance
Physician Services
Net revenues from the segment were $1.77 billion, reflecting an increase of 13.2% year over year. The revenue growth was driven by 8.2% contribution from acquisitions and 2.7% from same contracts and 2.3% from new contracts.
Adjusted EBITDA was $150.1 million, unchanged year over year.
Ambulatory Services
Net revenues were $307.6 million, down 2.6% year over year, led by weather- and flu-related procedure cancellations.
For the reported quarter, adjusted EBITDA was $57.5 million, down 4.5% year over year.
Financial Update
Envision Healthcare had cash and cash equivalents of $767.4 million, down 1.4% year over year.
At Mar 31, 2018, Envision had total debt outstanding of $4.7 billion. The company’s ratio of total net debt to EBIDTA ratio was 4.2 times at the end of first-quarter 2018.
Net cash provided by operating activities was $37.3 million as of Mar 31, 2018, down from $98.1 million as of Mar 31, 2017.
Second-Quarter 2018 Guidance
The company expects adjusted EPS within the range of 83 cents and 90 cents and adjusted EBITDA in the band of $234-$246 million.
Full-Year 2018 Guidance
The company affirmed its previously provided revenue guidance for 2018, which calls for net revenues in the range of $8.35 billion to $8.53 billion. It, however, pulled up the lower end of the guidance for adjusted EBIDTA and adjusted EPS.
The company expects adjusted EBIDTA of $965 million to $1 billion (versus $960 million to $1 billion) and adjusted EPS between $3.49 and $3.70 (versus $3.46 and $3.70).
Zacks Rank & Other Releases
Envision Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among the other firms in the medical sector that have reported fourth-quarter earnings so far, the bottom line at Centene Corp. (CNC - Free Report) , Aetna Inc and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>